Mangoceuticals, Inc. (MGRX)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Personal Products	456.02K	615.87K	731.49K	8.94K
Personal Products Growth	-25.96%	-15.81%	8083.16%	-
Total	456.02K	615.87K	731.49K	8.94K
Total Growth	-25.96%	-15.81%	8083.16%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
United States	456.02K	615.87K	731.49K	8.94K
United States Growth	-25.96%	-15.81%	8083.16%	-
Total	456.02K	615.87K	731.49K	8.94K
Total Growth	-25.96%	-15.81%	8083.16%	-

Data Source: S&P Global Market Intelligence Last updated: Apr 1, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 27, 2026

Data Sources Report a data error